Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2022 May;25(2):63-68.
doi: 10.1136/ebmental-2021-300309. Epub 2022 Mar 15.

Serum folate deficiency and the risks of dementia and all-cause mortality: a national study of old age

Affiliations

Serum folate deficiency and the risks of dementia and all-cause mortality: a national study of old age

Anat Rotstein et al. Evid Based Ment Health. 2022 May.

Abstract

Background: The association between serum folate deficiency and the risk of dementia in old age is unclear, perhaps owing to small sample sizes, the competing risk of mortality or reverse causation.

Objective: To examine the associations between serum folate deficiency and the risks of incident dementia and all-cause mortality in a large national sample of older adults.

Methods: A prospective cohort aged 60-75 years (n=27 188) without pre-existing dementia for at least 10 years, was tested for serum concentrations of folate and followed up for dementia or all-cause mortality. Serum folate deficiency was classified as present (<4.4 ng/mL), otherwise absent. HRs and 95% CIs from competing risks Cox models were fitted to quantify the associations between serum folate deficiency and the risks of dementia and all-cause mortality. To examine reverse causation, the analysis was stratified by duration of follow-up.

Findings: The presence compared with the absence of serum folate deficiency was associated with higher risks of dementia (HR=1.68; 95% CI 1.32 to 2.13; p<0.001) and all-cause mortality (HR=2.98; 95% CI 2.52 to 3.52; p<0.001). Evidence for reverse causation were moderate for dementia and mild for all-cause mortality.

Conclusions: Serum concentrations of folate may function as a biomarker used to identify those at risk of dementia and mortality; however, reverse causation is likely. Further research is needed to examine the role of serum folate deficiency in dementia aetiology.

Clinical implications: Serum folate deficiency in older adults requires monitoring and treatment for preventative measures and/or as part of implemented therapeutic strategies.

Keywords: adult psychiatry; delirium & cognitive disorders.

PubMed Disclaimer

Conflict of interest statement

Competing interests: None declared.

Figures

Figure 1
Figure 1
The association between serum folate deficiency and the risks of dementia and all-cause mortality. Note: HR: HR from the Cox regression model; CI: Wald two-sided 95% CI; p value: p value for test of the hypothesis HR=1 versus the hypothesis HR≠1. Reference group=serum folate deficiency absent; non-reference group=serum folate deficiency present.
Figure 2
Figure 2
Cumulative incidence curves of dementia and all-cause mortality
Figure 3
Figure 3
Serum folate concentrations and dementia or all-cause mortality

References

    1. Brattström L, Lindgren A, Israelsson B, et al. Homocysteine and cysteine: determinants of plasma levels in middle-aged and elderly subjects. J Intern Med 1994;236:633–41. 10.1111/j.1365-2796.1994.tb00856.x - DOI - PubMed
    1. Clarke R, Grimley Evans J, Schneede J, et al. Vitamin B12 and folate deficiency in later life. Age Ageing 2004;33:34–41. 10.1093/ageing/afg109 - DOI - PubMed
    1. Flood VM, Smith WT, Webb KL, et al. Prevalence of low serum folate and vitamin B12 in an older Australian population. Aust N Z J Public Health 2006;30:38–41. 10.1111/j.1467-842X.2006.tb00084.x - DOI - PubMed
    1. Reynolds EH, Rothfeld P, Pincus JH. Neurological disease associated with folate deficiency. Br Med J 1973;2:398–400. 10.1136/bmj.2.5863.398 - DOI - PMC - PubMed
    1. Baumgart M, Snyder HM, Carrillo MC, et al. Summary of the evidence on modifiable risk factors for cognitive decline and dementia: a population‐based perspective. Alzheimer's &amp; Dementia 2015;11:718–26. 10.1016/j.jalz.2015.05.016 - DOI - PubMed